292 related articles for article (PubMed ID: 28600720)
1. Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.
Sun Z; Lan X; Li S; Zhao H; Tang Z; Xi Y
Int J Hematol; 2017 Oct; 106(4):476-483. PubMed ID: 28600720
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
Bain J; Meyer A
Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
[TBL] [Abstract][Full Text] [Related]
4. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.
Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH
J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
Vo QA; Lin JK; Tong LM
Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for heparin-induced thrombocytopenia.
Greinacher A
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
9. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
Harenberg J; Jörg I; Fenyvesi T; Piazolo L
J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
[TBL] [Abstract][Full Text] [Related]
11. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
Warkentin TE
Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
[TBL] [Abstract][Full Text] [Related]
12. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
John TE; Hallisey RK
Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183
[TBL] [Abstract][Full Text] [Related]
13. A comparison of lepirudin and argatroban outcomes.
Smythe MA; Stephens JL; Koerber JM; Mattson JC
Clin Appl Thromb Hemost; 2005 Oct; 11(4):371-4. PubMed ID: 16244762
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"?
Seidel H; Kolde HJ
Clin Appl Thromb Hemost; 2018 Mar; 24(2):287-294. PubMed ID: 28320219
[TBL] [Abstract][Full Text] [Related]
15. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
16. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.
Nikolsky E; Dangas GD
Semin Thromb Hemost; 2004 Jun; 30(3):305-14. PubMed ID: 15282653
[TBL] [Abstract][Full Text] [Related]
18. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
Abel EE; Kane-Gill SL; Seybert AL; Kellum JA
Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938
[TBL] [Abstract][Full Text] [Related]
19. Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.
Colarossi G; Maffulli N; Trivellas A; Schnöring H; Hatam N; Tingart M; Migliorini F
Int J Clin Pharm; 2021 Aug; 43(4):825-838. PubMed ID: 33774764
[TBL] [Abstract][Full Text] [Related]
20. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
Greinacher A; Janssens U; Berg G; Böck M; Kwasny H; Kemkes-Matthes B; Eichler P; Völpel H; Pötzsch B; Luz M
Circulation; 1999 Aug; 100(6):587-93. PubMed ID: 10441094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
